baber/WOPTO huggingface dataset:
Patent NZ-534161-A (NZ)
Title: Use of polymers in fabrics and clothing used for protection against harmful chemical or biochemical agents
Inventor: BREWER STUART ANSON
IPC: C08J5/18
Filed: 2003-01-17
Abstract: Disclosed herein is a use of a polymer composition comprising polyethylenimine and one or both of polyvinyl alcohol and polyvinyl alcohol co-ethylene and optionally a cross-linking agent such as a dibasic acid for protection against harmful and noxious agents, wherein the polymer composition provides a substantial permeability to water vapour. A laminate suitable for providing protection against harmful, noxious, chemical or biochemical warfare agents, wherein the laminate comprises a layer of a polymer composition comprising polyethylenimine and one or both of polyvinyl alcohol and polyvinyl alcohol co-ethylene is also disclosed. Protective fabrics and clothing made from these laminates are suitable for emergency services and armed forces world-wide to provide protection against harmful and noxious agents.
Patent NZ-535845-A (NZ)
Title: A teat cup carrier in the form of a robot movable relative to a movable platform
Inventor: VAN DEN BERG KAREL
IPC: A01J7/04
Filed: 2004-10-08
Abstract: A teat cup carrier is designed to be able to co-operate with a feed platform, which teat cup carrier is freely movable relative to the feed platform. The teat cup carrier carries, besides teat cups, further milking elements for milking an animal, the further milking elements including at least a milk storage vessel for storing milk, a milking vacuum source and a pulsation vacuum source. The milk storage vessel is provided with a milk outlet. The freely movable teat cup carrier is a self-propelled (autonomous) mobile teat-cup-carrying robot and comprises a control unit for controlling the functioning of the mobile teat-cup-carrying robot.
Patent NZ-547739-A (NZ)
Title: Electrical connector for data and energy supply
Inventor: NIETHAMMER HANS-JUERGEN
IPC: H01R13/66
Filed: 2004-11-15
Abstract: An electrical connector (1) is disclosed. The electrical connector supplies power to data devices by means of data lines (7) which interconnect the data devices in a computer network. The devices have at least two device contacts (5) on the data device side and at least one mains contact (8) on the data line side. Connector (1) has a transformer integrated between the at least two device contacts (5) and the at least one mains contact (8), where the transformer combines an energy-data flow which is present at the at least one mains contact (8) with an energy flow at the one device contact and with at least one data flow at the other device contact.
Patent NZ-551545-A (NZ)
Title: Piperazine derivatives of alkyl oxindoles
Inventor: VOLK BALAZS
IPC: A61K31/40
Filed: 2005-05-11
Abstract: Disclosed is a 3-alkyl indol-2-one derivative of the general Formula (I) or a pharmaceutically acceptable acid addition salt thereof, wherein R1 and R2 independently represent hydrogen, halogen, alkyl, alkoxy or trifluoromethyl; R3 is hydrogen; m is 1, 2, 3 or 4; Q represents nitrogen, or a CH group, and wherein the other substituents are as defined herein. Of particular importance are the compounds 3-[4-(4-pyridine-2-yl-piperazine-1-yl)-butyl]-1,3-dihydro-2H-indol-2-one, 3-{4-[4-(7-chloro-2,3-dihydrobenzo[1,4]-dioxin-5-yl)-piperazine-1-yl]-butyl}-1,3-dihydro-2H-indol-2-one, 5-fluoro-3-[4-(4-pyridin-2-yl-piperazine-1-yl)-butyl]-1,3-dihydro-2H-indol-2-one, 6-fluoro-3-[4-(4-pyridin-2-yl-piperazine-1-yl)-butyl]-1,3-dihydro-2H-indol-2-one, 3-{4-[4-(3-methoxyphenyl)-piperazine-1-yl]-butyl}-1,3-dihydro-2H-indol-2-one, 3-{4-[4-(7-chloro-2,3-dihydrobenzo[1,4]-dioxin-5-yl)-piperazine-1-yl]-butyl}-5-fluoro-1,3-dihydro-2H-indol-2-one, 3-{4-[4-(5-chloro-2-methoxyphenyl)-piperazine-1-yl]-butyl}-1,3-dihydro-2H-indol-2-one and 5-fluoro-3-{4-[4-(3-methoxyphenyl)-piperazine-1-yl]-butyl}-1,3-dihydro-2H-indol-2-one. Further disclosed is a pharmaceutical composition which comprises as an active ingredient at least one compound as defined above and wherein the pharmaceutical composition is suitable for the treatment or prophylaxis of disorders of the central nervous system and psychosomatic disorders including anxiety syndrome, panic disease, compulsive disease, social phobia, agoraphobia, phobias connected to specific situations, stress disorders, post-traumatic stress disorders, post-traumatic memory disorder, cognitive disorder, sexual dysfunction of central nervous system origin, depression, schizophrenia, neurodegeneration followed by mental decline, Alzheimer's disease, stroke, dementias, gastrointestinal diseases and cardiovascular diseases.
Patent NZ-555244-A (NZ)
Title: Manufacture process for pharmaceutical product allowing delivery of a plurality of active agents
Inventor: FINKELMEIER STEVEN D
IPC: A61K47/44
Filed: 2005-11-18
Abstract: Disclosed is a pharmaceutical product comprising: a plurality of solid tablet components, wherein at least two of said plurality of solid tablet components have active agents, the pharmaceutical product being produced by a process of independently forming said plurality of solid tablet components by compression molding and assembling said plurality of solid tablet components into a single delivery vehicle, wherein said plurality of solid tablet components are interlocked via a mechanical connection. Also disclosed is a method of producing said pharmaceutical product.
Patent NZ-560636-A (NZ)
Title: Bulk bag filler with hook latch mechanism
Inventor: STERNER KEITH W
IPC: B65B1/06
Filed: 2006-02-07
Abstract: A bulk bag filler is provided having a frame assembly, a bag filling head, rotatable hooks for engaging bag loops and latch assemblies to engage the rotatable hooks. Each of the latch assemblies include an actuatable latch pin to release the rotatable hook, and upon release, the latch assemblies are gravity driven to return to a latching position in which the rotatable hooks are re- engageable. A method for loading a bulk bag with a bulk material is also provided.
Patent NZ-562730-A (NZ)
Title: Brake mechanism for lift with auxilliary movable friction plate providing multiple friction braking surfaces
Inventor: FISCHER DANIEL
IPC: F16D65/28
Filed: 2007-10-23
Abstract: Brake equipment, particularly for a lift installation, comprises a static element (1); a movable element (2) which is movable relative to the static element in a first degree of freedom (<p; x), wherein selectably a first frictional contact can be produced in a first contact surface (6.1) between the static element (1) and the movable element (2) by a controllable normal force (FN) acting in a second degree of freedom (y), in which a first friction force (FR1) opposes movement of the movable element relative to the static element (1); at least one relative element (3), wherein a second frictional contact is produced in a second contact surface (6.2) between the movable element (2) and the at least one relative element (4) by the normal force (FN), in which a second friction force (FR2) opposes movement of the movable element relative to the relative element; at least one actuating element (4) which is fixed in the first degree of freedom (tp; y) relative to the static element (1), wherein a third frictional contact is produced in a third contact surface (6.3) between the at least one actuating element (4) and the at least one relative element (3) by the normal force (FN), in which a third friction force (FR3) opposes movement of the relative element (3) relative to the actuating element (4). The at least one relative element (3) is movable in the first degree of freedom (<p; x) relative to the static element between a normal position (A) and a braking position (B), wherein the relative element (3) is resiliently biased into the normal position (A). The second and third contact surfaces (6.2, 6.3) are so constructed that a maximum second friction force (FR2max) is greater than a maximum third friction force (FR3max).
Patent NZ-563800-A (NZ)
Title: Air cell with modified sealing tab
Inventor: BARTLING BRANDON A
IPC: H01M50/198
Filed: 2007-11-28
Abstract: An air depolarized battery with an improved sealing member for sealing the air inlet port(s) of the battery before use is disclosed. The sealing member has areas of relatively high and low permeability, with an area of low permeability over at least a portion of an air inlet port. The rate of flow of air through the low permeability area and into the battery can be easily modified to maintain a desired battery open circuit voltage during battery storage to allow activation of the battery within a short time after removal of the sealing member, while minimizing losses in discharge capacity before use.
Patent NZ-564368-A (NZ)
Title: Prism-type electrical converter using a vectorial sum of two phases to create a non-existent third phase
Inventor: MENDOZA CEBALLOS VICENTE ARTURO
IPC: H01F27/24
Filed: 2006-05-22
Abstract: Disclosed is a prism electric converter to generate, transmit, distribute, and supply electric power. The system includes a three-phase magnetic system having a magnetic core; an electric system; and a cooling system or a thermal control system. The convertor has an angular displacement of 120 or 240 electric degrees, and is based on a vectorial sum of a first phase (s1) and a second phase (s2) to generate a non-existing third phase (s3). The first phase (s1) is formed by a first section a1 and a second section a2, the second phase (s2) is formed by a first section b1 and a second section b2, and the third phase (s3) is formed by a first section c1 and a second section c2. The section c1 is formed by the first section a1 of the first phase and the first section b1 of the second phase and the section c2 is formed by the second section a2 of the first phase and the second section b2 of the second phase. The voltages between the phases are symmetrical, and the voltages between the phases and neutral n are symmetrical. There are feeding voltages and output voltages between s1 and s2, between s2 and s3, between s1 and s3, between s1 and neutral n, s2 and neutral n, and between s3 and neutral n.
Patent NZ-565877-A (NZ)
Title: System and method for inductively powering a remote device
Inventor: BAARMAN DAVID W
IPC: H02J5/00
Filed: 2006-09-22
Abstract: Disclosed is a circuit for powering a remote device (8). The circuit comprises: an inverter (10) operating at an operating frequency; a tank circuit (20), which includes a capacitor (22) and an inductor (24) for transferring power to the remote device; a phase comparator (35); and a disabling means (38). The phase comparator compares the phase of the voltage supplied to the tank circuit with the phase of the voltage between the capacitor and inductor and generates a first phase comparison. The disabling means disables the inverter as a function of the first phase comparison.
Patent NZ-569004-A (NZ)
Title: Immunochromatographic detection method for multidrug-resistant staphylococcus and diagnostic kit
Inventor: ITO HIROMI
IPC: G01N33/543
Filed: 2006-12-14
Abstract: Disclosed is a method for detecting a bacterium that produces a cell-wall-synthesizing enzyme, PBP2'. The method comprises detection of a cell-wall-synthesizing enzyme PBP2' via immunochromatography detection based on an antigen-antibody reaction using an antibody that specifically detects PBP2'. The method involves the use of an immunochromatography detection device comprising on a sheet-like solid-phase support; a sample supply site to which a sample solution deduced to contain a bacterium producing a cell-wall-synthesizing enzyme, PBP2' or a solution deduced to contain PBP2' released from the cell wall via sample pre-treatment is supplied; a labelled reagent site that holds a labelled reagent which comprises a labelled antibody binding specifically to PBP2', such that the reagent is able to spread across the solid-phase support; and a capture reagent site on which a capture reagent capable of specifically binding to and capturing a complex of PBP2' by capturing the antibody and the labelled reagent that comprises a labelled antibody has been immobilized, wherein the capture reagent site comprises a sulfobetaine-type surfactant.
Patent NZ-578656-A (NZ)
Title: Extended-release dosage form
Inventor: BHAT PAVAN
IPC: A61K9/50
Filed: 2008-01-24
Abstract: Disclosed is a pharmaceutical formulation, comprising sustained release particles having an inner core bead comprising a granulate of an active pharmaceutical ingredient, an intermediate coating substantially surrounding said inner core bead comprising a mixture of a water soluble component and a water insoluble component, and an outer coating substantially surrounding said intermediate coating comprising a pH independent polymer, wherein said formulation provides a dissolution profile in aqueous media such that about 50% to about 85% of said active pharmaceutical ingredient is released after about 14 hours, and about 75% to about 100% of said active pharmaceutical ingredient is released after about 24 hours. A method of preparing the above pharmaceutical formulation is also disclosed.
Patent NZ-580764-A (NZ)
Title: Apparatus for positioning milking equipment including equipment to sense movement of the equipment
Inventor: CRESPO ERIC
IPC: A01J5/017
Filed: 2008-05-07
Abstract: Disclosed is a device for positioning milking equipment (11). The device has a support beam (10) and a first part (13) for holding milking equipment (15), with the first part engagable with the support beam and is movable along the support beam between a first (17) and a second (19) position. A second part (25) is arranged fixedly in or at the support beam between the first and second positions. One of the first and second parts includes sensing means (13c) provided for sensing each time the first part is moved passed the second part and indicating means connected to the sensing means and provided for indicating whether the first part is moved to the first position or to the second position based on the sensing.
Patent NZ-581716-A (NZ)
Title: Multiple analysis of blood samples
Inventor: BUFFIERE FREDERIC
IPC: G01N33/537
Filed: 2008-06-06
Abstract: Provided is an in vitro method for identifying antigenic molecules carried by erythrocytes and/or anti-erythrocyte antibodies of an individual, wherein the antigenic molecules are erythrocyte membrane antigens constituting the blood groups, activated serum complement fractions carried by the erythrocytes, or antibodies present at the surface of the sensitized erythrocytes; comprising the steps of, a) identifying a plurality of antigenic molecules carried by erythrocytes in a biological sample, by (i) bringing said sample containing erythrocytes into contact, in a single test receptacle, or in several separate test receptacles, with groups of distinguishable beads, each group of distinguishable beads carrying a given antibody, specific for an antigenic molecule carried by erythrocytes, which differs from one group of beads to the other, under conditions which allow the erythrocytes to bind to the antibodies, without agglutination, said erythrocytes being labelled before or after they have been brought into contact with said groups of beads, (ii) eliminating the erythrocytes which have not bound to said antibodies, and (iii) identifying the group of beads having bound the labelled erythrocytes, thereby allowing the identification of the antigens carried by the erythrocytes detected.
Patent NZ-584550-A (NZ)
Title: Adjustable pipe coupling assembly
Inventor: ESDAILE DOUGLAS ALAN
IPC: E04H15/34
Filed: 2008-09-19
Abstract: Disclosed is an adjustable pipe coupling assembly (10) with a first clamp (30), a second clamp (32), and means (38, 40, 44) for rotating the clamps independently about a first common axis shared by the clamps and extending vertically. The first clamp (30) includes a first pair of opposed ears (52, 54) spaced apart so as to allow a first pipe (16) to be located between them. Each one of the opposed ears (52, 54) has a hole (56, 58) formed through it, the pair of holes (56, 58) sharing a second common axis extending in a first horizontal plane and are adapted to receive a bolt or pin (60) which engages the first pipe (16). This allows the first pipe to pivot about the second common axis. The second clamp (32) includes the same features as the first clamp, allowing a second pipe to rotate about a third common axis which is perpendicular to the second common axis and extending in a second horizontal plane. The arrangement is such that, in use, the rotating means rotate the clamps so as to adjust the horizontal angle between the second and third common axes, and each of the first and second pivot means pivot their respective pipe so as to adjust the vertical angle between the first and second pipes
Patent NZ-588498-A (NZ)
Title: Method and apparatus for radially expanding a suspended container body with a radially adjustable resilient punch tool
Inventor: ROETERDINK JOHAN WILLEM
IPC: B21D22/02
Filed: 2009-04-21
Abstract: 588498 A method and apparatus for radially expanding a container body such as a can is disclosed. The container body (10) is provided with a flange which is circumferentially clamped to suspend the container body. The container body (10) is radially expanded from the clamped end towards the suspended end. The radial expansion is carried out using a means (37, 38) for radially adjusting the diameter of a continuous circumferential expansion surface (39) of a resilient punch tool.
Patent NZ-589729-A (NZ)
Title: Pallet for transporting and lifting a wind turbine hub having connectors for two types of lifting machine
Inventor: POULSEN HENNING
IPC: B66C1/00
Filed: 2010-12-06
Abstract: Wind turbine hub transportation device (100) is disclosed. The transportation device (100) comprises of a hub receiving surface (102), a first beam (106), a second beam (108) and a centre part (110) connecting the first beam and the second beam. The first and second beams each have at least one connector (112, 116) adapted for connecting each beam with a first lifter for lifting the transportation device (100) while the wind turbine hub is mounted to it. The centre part (110) has a centre connector (122) adapted for making a connection to a second lifter also while the wind turbine hub is mounted to it. The transportation device (100) allows for the simultaneous attachment to the first lifter and the second lifter and for mounting the wind turbine hub at an installation site. A method of use is also disclosed.
Patent NZ-592224-A (NZ)
Title: Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
Inventor: FANCELLI DANIELE
IPC: A61K31/167
Filed: 2009-09-23
Abstract: Disclosed is a compound of formula I (acrylamido derivatives), such as (E)-N-[3-(Benzyl-methyl-amino)-phenyl]-3-(3-hydroxy-4-methoxy-phenyl) acrylamide, (E)-N-[2-Chloro-3-(pyridin-4-ylmethoxy)-phenyl]-3-(3-hydroxy-4-methoxy-phenyl) acrylamide hydrochloride and (E)-3-(3-Hydroxy-4-methoxy-phenyl)-N-{ 3-[(pyridin-4-ylmethyl)-amino]-phenyl} acrylamide, for treatments of heart-related, brain-related and metabolic disorder-related diseases.
Patent NZ-593360-A (NZ)
Title: Filter for use in food processing
Inventor: PRINZ ARTUR
IPC: A01J25/00
Filed: 2009-12-18
Abstract: 593360 Use of a filter (10) in the processing of pasty foods is disclosed. The filter has a closed housing (12) with an inlet (16) for the product to be filtered, a drain (20) for the filtered product, an output (24) for the filtered-out residue and a filter insert (14) located between the feed inlet (16) and drain (20). The insert (14) has a cylindrical filter wall through which the product flows in the radial direction from the inside to the outside. A rotatable core element (30) is located coaxially in the filter insert (14) defining annulus (36). The core element (30) is dimensioned so that the annulus (36) enables a constant flow of product. On the outer periphery of the core element (30) there is at least one scraper (38) that scrapes on the inner surface of the filter wall as the core element (30) turns for removing the residue. The filter (10) may be used for filtering processed cheese.
Patent NZ-596770-A (NZ)
Title: Food products comprising zeolites
Inventor: BRUNELLO DARIO
IPC: A23L25/00
Filed: 2010-05-12
Abstract: Abstract - 596770 Disclosed is the use of a food product in the manufacture of a medicament for the reduction of absorption of ethanol ingested via the consumption of an alcoholic drink, the food product comprising: micronised zeolite (such as clinoptilolite) wherein at least 90% of the granules of said micronised zeolite have a particle size greater than 0.1 micons; and a pharmaceutically acceptable carrier, and wherein the food product may be selected from anyone of drinks, baked products, sweet or savoury, bread, pizza, focaccia, crackers, biscuits, tarts, snacks, sweets, crisps, nuts, sweet or salted bars, tortilla, fresh or dry pasta and ready meals and sauces.
Patent NZ-603207-A (NZ)
Title: Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
Inventor: WOLLIN STEFAN-LUTZ
IPC: A61K31/22
Filed: 2007-07-03
Abstract: 603207 Disclosed is a pharmaceutical composition and a combination product comprising Roflumilast also known as 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4- (difluoromethoxy)benzamide; and either simvastatin also known as (1S,3R,7S,8S,8aR)-8-{ 2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl} -3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate or atorvastatin also known as (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; and a pharmaceutically acceptable auxiliary. In the combination product the two actives are adapted for simultaneous or sequential administration. Also disclosed is the process for making the composition and the use of the composition for the manufacture of a medicament for the treatment of an inflammatory pulmonary disease.
Patent NZ-609126-A (NZ)
Title: Methods and compositions for the evaluation of renal injury using hyaluronic acid
Inventor: ANDERBERG JOSEPH
IPC: G01N33/50
Filed: 2011-09-23
Abstract: Disclosed is a method for evaluating renal status in a subject not receiving renal replacement therapy, comprising: - performing one or more assays configured to detect HA in a body fluid sample obtained from the subject to provide one or more assay results, each assay result(s) comprising a measured concentration of HA in the body fluid sample; and - correlating the assay result(s) to one or more of risk stratification, prognosis, classifying and monitoring of the renal status of the subject, said correlating comprising comparing a measured concentration of HA to a threshold concentration of HA obtained from a population study.
Patent NZ-628993-A (NZ)
Title: Pharmaceutical formulations comprising ccr3 antagonists
Inventor: FETSCHER ALFRED
IPC: A61P29/00
Filed: 2013-04-02
Abstract: The disclosure relates to pharmaceutical compositions containing compounds of formula (1) wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate, j is 1 or 2, first diluent, a second diluent, a disintegrant, a lubricant and optionally a binder, wherein the pharmaceutical composition comprises: 10-90 % active ingredient; 5-70 % first diluent; 5-30 % second diluent; 0-30 % binder; 1-12 % disintegrant; and 0.1-3 % lubricant, wherein the first and the second diluents are selected from the group consisting of cellulose powder, dibasic calciumphosphate anhydrous, dibasic calciumphosphate dihydrate, erythritol, low substituted hydroxypropyl cellulose, mannitol, pregelatinized starch and xylito 1, wherein the pharmaceutical composition is in the dosage form of a film-coated tablet comprising 2-4 % film coat. Also disclosed are processes for the preparation of tablet formulations, and the use of these pharmaceutical compositions to treat diseases connected with the CCR3 receptor.